Biomedical reports最新文献

{"title":"Effect of the COVID‑19 pandemic on the management and outcomes of patients with traumatic injuries (Review).","authors":"Gheorghe-Jean Boldea,&nbsp;Daniel Cosmin Caragea,&nbsp;Pantelie Nicolcescu,&nbsp;Vlad Pădureanu,&nbsp;Dumitru Rădulescu,&nbsp;Ana Maria Boldea,&nbsp;Ion Georgescu,&nbsp;Eugen Florin Georgescu","doi":"10.3892/br.2023.1658","DOIUrl":"https://doi.org/10.3892/br.2023.1658","url":null,"abstract":"<p><p>During the COVID-19 pandemic, ~10% of the global population was officially affected, resulting in diverse changes, ranging from shopping habits to stringent hospital protocols. This article sought to provide a concise summary of relevant data concerning the interplay between COVID-19 and trauma, encompassing the entire trajectory from presentation to hospital discharge. Throughout the pandemic, there was a noticeable reduction in trauma presentations, while the ranking of injury mechanisms remained largely unchanged. To ensure essential surgical support, protocols were adjusted accordingly. Although there were some less significant changes in injury severity score, hospital length of stay, intensive care unit stay and mortality, the overall patient outcomes appeared to improve. In conclusion, the COVID-19 pandemic led to a decline in trauma cases and an enhancement in patient outcomes. However, regrettably, certain mechanisms of injury saw an increase in frequency. To cope with the epidemiological context, management strategies were adapted, and unutilized resources were redirected to cater to the care of COVID-19 patients.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f1/a6/br-19-04-01658.PMC10511947.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41106953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Gastric metastasis in patients with leiomyosarcoma: A case report.","authors":"Teruya Uchiyama,&nbsp;Tomoki Nakamura,&nbsp;Kenta Nakata,&nbsp;Ryohei Adachi,&nbsp;Tomohito Hagi,&nbsp;Kunihiro Asanuma,&nbsp;Akihiro Sudo","doi":"10.3892/br.2023.1657","DOIUrl":"10.3892/br.2023.1657","url":null,"abstract":"<p><p>Soft tissue sarcomas (STS) are very rare tumors, accounting for <1% of all malignancies. Leiomyosarcoma (LMS), accounts for 10-20% of STS. Gastric metastasis of LMS is extremely rare, and only a few cases have been reported. In the present report, two clinical cases of LMS with gastric metastasis. In the present cases, the metastases presented as a solitary lesion and was located in the upper body anterior wall in case 1, and body-greater curvature in case 2. It is debatable whether to perform any local treatment for gastric metastasis due to its poor prognosis. However, the progression of metastatic cancer in the stomach can lead to gastric bleeding, abdominal pain, and dysphagia, which may further shorten survival and decrease a patient's quality of life. Therefore, metastasectomy was performed in the present cases. This should be considered if digestive tract symptoms occur during the treatment of LMS.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f2/3d/br-19-04-01657.PMC10511945.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41105518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence of <i>Ureaplasma urealyticum</i>, <i>Mycoplasma hominis</i> and <i>Chlamydia trachomatis</i> in symptomatic and asymptomatic patients.","authors":"Ana Cutoiu,&nbsp;Daniel Boda","doi":"10.3892/br.2023.1656","DOIUrl":"https://doi.org/10.3892/br.2023.1656","url":null,"abstract":"<p><p>The purpose of the present study was to assess the prevalence of <i>Ureaplasma urealyticum</i> (<i>U. urealyticum</i>), <i>Mycoplasma hominis</i> (<i>M. hominis</i>) and <i>Chlamydia trachomatis</i> (<i>C. trachomatis</i>) in a Romanian population considering the presence or absence of genital symptoms. Urethral and vaginal samples were collected from patients presenting at 'Ponderas' Academic Hospital (Bucharest, Romania) from January 2021 to December 2021. A total of 266 samples were obtained from two groups of patients: Symptomatic subjects with urethritis, prostatitis, vaginitis or both urethritis and prostatitis (n=59; 22%), and asymptomatic subjects (n=207; 78%). <i>Mycoplasma</i> and <i>Chlamydia</i> kits were used to assess the presence of <i>U. urealyticum</i> and <i>M. hominis</i>, and <i>C. trachomatis</i>, respectively. The symptomatic subjects comprised 27 patients with urethritis symptoms, of whom 4 (15%) were infected with <i>U. urealyticum</i> and 1 (4%) was infected with <i>C. trachomatis</i>. In addition, 23 (9%) of the patients had prostatitis-like symptoms, which in 3 (13%) of the patients was associated with <i>U. urealyticum</i> and in 1 patient (4%) was associated with <i>C. trachomatis</i>. None of the symptomatic patients were infected with <i>M. hominis</i>. By contrast, 29 (14%) of the asymptomatic patients were discovered to be infected with <i>U. urealyticum</i>, 13 (6%) were coinfected with both Mollicutes and 4 (2%) were infected with <i>C. trachomatis</i>; only 1 patient was positive for <i>M. hominis</i> alone. Two patients (14%) who presented with <i>U. urealyticum</i> and <i>M. hominis</i> coinfection were also infected with <i>C. trachomatis</i>. No patient with <i>U. urealyticum</i> or <i>M. hominis</i> alone was also positive for <i>C. trachomatis</i>. Therefore, the most frequently identified pathogen populating the genital tract in both males and females was <i>U. urealyticum</i>, followed by coinfection with <i>U. urealyticum</i> and <i>M. hominis</i>, and <i>C. trachomatis</i>. As these infections are asymptomatic in numerous cases, this suggests that a thorough screening should be mandatory.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/78/3e/br-19-04-01656.PMC10511948.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41117667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Suppression of antitumor cytokine IL‑24 by PRG4 and PAI‑1 may promote myxoid liposarcoma cell survival.","authors":"Kosuke Oikawa,&nbsp;Masahiko Kuroda,&nbsp;Shogo Ehata","doi":"10.3892/br.2023.1642","DOIUrl":"https://doi.org/10.3892/br.2023.1642","url":null,"abstract":"<p><p>Suppression of the antitumor cytokine interleukin-24 (IL-24) is critical for the survival of myxoid liposarcoma (MLS) cells. It has been previously demonstrated by the authors that an MLS-specific chimeric oncoprotein, translocated in liposarcoma-CCAAT/enhancer-binding protein homologous protein (TLS-CHOP), supresses <i>IL24</i> mRNA expression via induction of proteoglycan 4 (PRG4) to sustain MLS cell proliferation. However, IL-24 has also been revealed to be suppressed by the ubiquitin-proteasome system in human ovarian and lung cancer cells. Therefore, the aim of the present study was to elucidate the mechanism of IL-24 suppression in MLS cells. The results revealed that the proteasome inhibitor, MG-132, induced cell death in MLS cells <i>in vitro</i>; this effect was reduced following IL-24 knockdown. This indicated that proteasomal degradation of IL-24 may be an important process for MLS cell survival. In addition, it was also previously revealed by the authors that knockdown of plasminogen activator inhibitor-1 (PAI-1), a TLS-CHOP downstream molecule, suppressed the growth of MLS cells, thus instigating the investigation of the effect of PAI-1 on IL-24 expression in MLS cells. Double knockdown of PAI-1 and IL-24 negated the growth-suppressive effect of PAI-1 single knockdown in MLS cells. Interestingly, PAI-1 single knockdown did not increase the mRNA expression of <i>IL24</i>, but it did increase the protein abundance of IL-24, indicating that PAI-1 suppressed IL-24 expression by promoting its proteasomal degradation. Moreover, treatment of MLS cells with a PAI-1 inhibitor, TM5275, induced IL-24 protein expression and apoptosis. Collectively, the results of the present as well as previous studies indicated that IL-24 expression may be suppressed at the transcriptional level by PRG4 and at the protein level by PAI-1 in MLS cells. Accordingly, PAI-1 may represent an effective therapeutic target for MLS treatment.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442737/pdf/br-19-03-01642.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10122701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A case of acquired hemophilia A after pancreaticoduodenectomy for distal cholangiocarcinoma.","authors":"Makoto Takahashi,&nbsp;Yasuhiro Morita,&nbsp;Tatsuya Hayashi,&nbsp;Taku Higashihara,&nbsp;Keishi Kawasaki,&nbsp;Shunsuke Sato,&nbsp;Shota Yokose,&nbsp;Shu Sasaki,&nbsp;Kaoruko Funakoshi,&nbsp;Takayoshi Sasaki,&nbsp;Daren Zhou,&nbsp;Akinori Ichinose,&nbsp;Hideo Ohtsuka,&nbsp;Yuji Ishibasi,&nbsp;Fumihiko Hatao,&nbsp;Keiki Shimizu,&nbsp;Nobuo Isono,&nbsp;Naomi Sasaki,&nbsp;Yasuji Kozai,&nbsp;Haruka Okada,&nbsp;Yushi Chikasawa","doi":"10.3892/br.2023.1643","DOIUrl":"https://doi.org/10.3892/br.2023.1643","url":null,"abstract":"<p><p>Acquired hemophilia A (AHA) is a rare disease that results from factor VIII inhibitors causing abnormal coagulation, and certain cases may develop after highly invasive surgery. The present case study reports on a 68-year-old male patient who developed AHA after undergoing a subtotal stomach-preserving pancreatoduodenectomy for distal cholangiocarcinoma. The patient experienced complications after surgery, requiring reoperation on postoperative day (PD) 5 due to rupture of the Braun's enterostomy. On PD 6, angiography was performed after bleeding was detected in the jejunal limb, but hemostasis occurred spontaneously during the examination. Bleeding was observed again on PD 8 and direct surgical ligation was performed. On PD 14, bleeding recurred in the jejunal limb and angiography was performed to embolize the periphery of the second jejunal artery. During the procedure, the prothrombin time was normal, but only the activated partial thromboplastin time was prolonged. A close examination of the coagulation system revealed a decrease in factor VIII levels and the presence of factor VIII inhibitors, resulting in the diagnosis of AHA. Administration of steroids was initiated on PD 15 and, in addition to daily blood transfusions, activated prothrombin complex concentrate was administered to achieve hemostasis. The patient was discharged from the intensive care unit on PD 36 but later developed an intractable labial fistula due to suture failure at the gastrojejunostomy site. As the use of factor VIII inhibitors continued despite the administration of steroids, cyclophosphamide (CPA) pulse therapy was added at PD 58. However, CPA was ineffective and the administration of rituximab was initiated on PD 98. After 12 courses of rituximab, the patient tested negative for factor VIII inhibitors on PD 219. On PD 289, labial fistula closure was performed with continuous replacement of factor VIII and the patient was discharged on PD 342.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4d/c6/br-19-03-01643.PMC10442756.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10122708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Different responses of the MIO‑M1 Mueller cell line to angiotensin II under hyperglycemic or hypoxic conditions.","authors":"Ansgar Beuse,&nbsp;Heidrun L Deissler,&nbsp;Margrit Hollborn,&nbsp;Jan Darius Unterlauft,&nbsp;Catharina Busch,&nbsp;Matus Rehak","doi":"10.3892/br.2023.1644","DOIUrl":"https://doi.org/10.3892/br.2023.1644","url":null,"abstract":"<p><p>Members of the renin-angiotensin aldosterone system (RAAS) are expressed by various retinal tissues including Mueller glial cells. As the RAAS is hypothesized to play an important role in the pathogenesis of diseases that threaten vision, such as diabetic macular edema or retinal vein occlusion, the possible changes induced by exposure of the human cell line MIO-M1, an established model of Mueller cells, to angiotensin II or aldosterone for 6 h under hypoxic and/or hyperglycemic conditions were investigated. The mRNA expression levels of the members of the RAAS were assessed by reverse transcription-quantitative PCR, and the secretion of cytokines was assessed by ELISA. Under hyperglycemic conditions, the mRNA expression levels of the angiotensin-converting enzyme 2 (ACE2), angiotensin II receptors, AT₁ and AT₂, and the receptor of angiotensin (1-7) MAS1 were significantly higher after exposure to angiotensin II, and the expression of ACE2, AT₂, and IL-6 (a marker of inflammation) was significantly increased after treatment with aldosterone; the expression of the other targets investigated remained unchanged. Significantly more IL-6 was secreted by MIO-M1 cells exposed to hyperglycemia and angiotensin. When cells were cultured in a hypoxic environment, additional treatment with aldosterone significantly increased the mRNA expression levels of ACE, but significantly more ACE2 mRNA was expressed in the presence of angiotensin II. Under hypoxic plus hyperglycemic conditions, significantly less ACE but more AT₂ was expressed after treatment with angiotensin II, which also led to strongly elevated expression of IL-6. The mRNA expression levels of the angiogenic growth factor VEGF-A and secretion of the encoded protein were notably increased under hypoxic and hypoxic plus hyperglycemic conditions, irrespective of additional treatment with angiotensin II or aldosterone. These findings suggest that angiotensin II induces a pro-inflammatory response in MIO-M1 cells under hyperglycemic conditions despite activation of the counteracting ACE2/MAS1 signaling cascade. However, hypoxia results in an increased expression of angiogenic VEGF-A by these cells, which is not altered by angiotensin II or aldosterone.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2f/10/br-19-03-01644.PMC10442740.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10122702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Antiviral agents and disinfectants for foot‑and‑mouth disease (Review).","authors":"Takashi Onodera,&nbsp;Akikazu Sakudo,&nbsp;Katsuaki Sugiura,&nbsp;Makoto Haritani,&nbsp;Koichi Furusaki,&nbsp;Rikio Kirisawa","doi":"10.3892/br.2023.1639","DOIUrl":"https://doi.org/10.3892/br.2023.1639","url":null,"abstract":"<p><p>Fluorouracil, 5-azacytidine, 6-azauridine, ribavirin, favipiravir (T-705) and its derivative (T-1105) exhibit anti-foot-and-mouth disease virus (FMDV) effects. In particular, T-1105 exhibits promising results when administered to guinea pigs orally, and pigs in their feed. FMDV is excreted in the early stages of infection in aerosols and oral or nasal droplets from animals. T-1105 along with the FMDV vaccine can be used to combat foot-and-mouth disease (FMD) epidemics. Several studies have shown that sodium hypochlorous solutions are widely used to inactivate viruses, including FMDV. However, these solutions must be stored under cool and dark conditions to maintain their virucidal effects. Interestingly, a study indicated that the virucidal activity of a calcium bicarbonate solution with a mesoscopic structure (CAC-717) did not decrease after storage at room temperature for at least four years outside direct sunlight. Numerous lessons acquired from the 2010 FMD outbreak in Japan are relevant for the control of COVID-19. However, the widespread use of chlorite can cause environmental issues. Chlorite can be combined with nitrogen to produce chloramine or N-nitrosodimethylamine, which plays a role in carcinogenesis. Therefore, risk assessments should be conducted in aquatic environments. Moreover, there is a need to develop nonchlorine disinfectants that can be used during epidemics, including FMD. The approach of 'One Health' should be shared between the public health and veterinary fields to improve the management of viral outbreaks, including those due to FMD.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a2/3f/br-19-03-01639.PMC10442741.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10122707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"<i>In vitro</i> antioxidant and anticancer activities of <i>Smilax corbularia</i> extract combined with <i>Phellinus linteus</i> extract against breast cancer cell lines.","authors":"Alvi Jauharotus Syukriya,&nbsp;Wichanee Bankeeree,&nbsp;Sehanat Prasongsuk,&nbsp;Pattamawadee Yanatatsaneejit","doi":"10.3892/br.2023.1645","DOIUrl":"https://doi.org/10.3892/br.2023.1645","url":null,"abstract":"<p><p>Treatment with extracts from whole herbs has been reported to synergistically enhance the anticancer activities of therapeutic agents in recent studies. The present study evaluated the antioxidant and anticancer activities of <i>Smilax corbularia Kunth</i> (<i>S. corbularia</i>) and <i>Phellinus linteus</i> (<i>P. linteus</i>) crude extracts individually and in combination. <i>S. corbularia</i> was extracted using ethanol, whereas <i>P. linteus</i> was extracted using hot water. Both crude extracts underwent physiochemical characterization. Subsequently, the possible antioxidant activities of both crude extracts, individually and in combination, were evaluated using 2,2-Diphenyl-1-picrylhydrazyl and 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) assays. Their effects on breast cancer cell cytotoxicity, proliferation and apoptosis were then assessed. The crude <i>S. corbularia</i> extract obtained was found to have a high level of total phenolic content, whilst the crude <i>P. linteus</i> extract had high levels of total polysaccharide content. The total phenolic content and total polysaccharide content results of the combinations depended on the respective ratios of the individual extracts. <i>S. corbularia</i> alone and combination 3 (which contained 75% <i>S. corbularia</i>: 25% <i>P. linteus</i>) demonstrated the greatest radical scavenging activity, followed by combination 1 (50% <i>S. corbularia</i>: 50% <i>P. linteus</i>), combination 2 (25% <i>S. corbularia</i>: 75% <i>P. linteus</i>) and <i>P. linteus</i>. The toxicity results of the extract samples on the cancer cells corresponded with their antioxidant activity. In particular, certain combinations demonstrated clearer inhibitory effects on cell proliferation against three types of breast cancer cells compared with those exerted by the two individual extracts. However, induction of apoptosis was limited, with the degree of apoptosis observed to be #x003C;5%. These findings suggested that treatment with combinations of these two extracts could confer enhanced antioxidant and antiproliferative effects on breast cancer cells. Therefore, the potential of these two extracts in combination as anticancer agents warrants further investigation.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bb/6c/br-19-03-01645.PMC10442767.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10421775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A consolidated working classification of gastric cancer for histopathologists (Review).","authors":"Simona Costache,&nbsp;Maria Sajin,&nbsp;Sarah Wedden,&nbsp;Corrado D'Arrigo","doi":"10.3892/br.2023.1640","DOIUrl":"https://doi.org/10.3892/br.2023.1640","url":null,"abstract":"<p><p>Gastric cancer (GC) remains a disease with poor prognosis despite increasing availability of more effective targeted treatment. This may be in part due to the difficulty in selecting patients for appropriate treatment. Conventional taxonomic classifications of GC are ill-suited to make full use of recent advances in personalised therapy. In the past decade a number of molecular classifications have been proposed to address this; however, to date, there has been little implementation in the diagnostic routine. The lack of harmonisation between these classifications, the complexity and unavailability of some of the tests required plus the demands on time and resources, all contribute to poor uptake in the diagnostic routine. In the present study, these classifications were reviewed and an inclusive working classification that includes their main points, focuses on prognosis and treatment options and can be delivered using four on-slide tests (<i>in situ</i> hybridization for Epstein-Barr encoding region and immunohistochemistry for mismatch repair, E-cadherin and p53) is proposed. These tests can be performed on paraffin-embedded tissue and could be available in the majority of histopathology laboratories. The proposed classification also includes reflex testing for specific biomarkers relevant to treatment selection.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/30/56/br-19-03-01640.PMC10442765.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10122705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intraarticular management of chronic haemophilic arthropathy (Review).","authors":"Daniela Poenaru,&nbsp;Miruna Ioana Sandulescu,&nbsp;Delia Cinteza","doi":"10.3892/br.2023.1641","DOIUrl":"https://doi.org/10.3892/br.2023.1641","url":null,"abstract":"<p><p>Hemophilia is an inherited X-linked bleeding condition with predominant joint involvement due to intra-articular bleeding, hemosiderin deposition and the synovial hypertrophy that is responsible for cartilage destruction, joint deformity and malalignment, pain and functional restriction. Management of chronic arthropathy includes conservative and surgical approaches. Conservative therapies consist of pain modulation, oral drugs, physiotherapy and intra-articular agents. For the present review, the literature was searched for intra-articular agents and 20 papers on the use of corticosteroids (CS), hyaluronic acid (HA) and platelet-rich plasma (PRP), with different regimes of administration, were included. CS had a longer record of injection, with statistically significant pain reduction and functional improvement in the short-term and moderate persistence in the long-term. HA was able to improve the clinical and functional status of joints with moderate or severe hemophilia. PRP was relatively recently introduced to joint management and the results remain controversial. Different associations between the above-mentioned agents were proposed by studies including a small number of patients, producing comparable results. It was concluded that there is a need for extensive research on intra-articular agents, with stratification according to the severity of joint involvement. The lack of a blinded or placebo-controlled arm due to ethical aspects makes the task challenging.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/24/fe/br-19-03-01641.PMC10442758.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10122706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}